Preanalytical approaches to improve recovery of amyloid-β peptides from CSF as measured by immunological or mass spectrometry-based assays.
Alzforum,
Schauer SP, Mylott WR Jr, Yuan M, Jenkins RG, Rodney Mathews W, Honigberg LA, Wildsmith KR.
Schauer SP, Mylott WR Jr, Yuan M, Jenkins RG, Rodney Mathews W, Honigberg LA, Wildsmith KR.
Amyloid -β 1–42 (Aβ1–42) peptide is a well-established cerebrospinal fluid (CSF) biomarker for Alzheimer’s disease (AD).